Maria Inês Schmidt

Maria Inês Schmidt

Auto-generated profile, based on publicly available information

Maria Inês Schmidt

School of Medicine, Universidade Federal do Rio Grande do Sul, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2011 in The Lancet
Verified
Journal Article
Closed access
MSMaria Inês Schmidt
Maria Inês Schmidt
BDBruce Bartholow Duncan
Bruce Bartholow Duncan
GSGulnar Azevedo e Silva
Gulnar Azevedo e Silva
AMAna Maria Menezes
Ana Maria Menezes
CMCarlos Augusto Monteiro
Carlos Augusto Monteiro
PMPaulo Menezes
Paulo Menezes

1 February 2014 in International Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
MSMaria Inês Schmidt
Maria Inês Schmidt
BDBruce Duncan
Bruce Duncan
JMJosé Geraldo Mill
José Geraldo Mill
PLP. A. Lotufo
P. A. Lotufo
DCDóra Chor
Dóra Chor
IBIsabela M Bensenor
Isabela M Bensenor
Chronic diseases are a global problem, yet information on their determinants is generally scant in low- and middle-income countries. The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) aims to contribute relevant information regarding the development and progression of clinical and subclinical chronic diseases, particularly cardiovascular diseases and diabetes, in one such setting. At Visit 1, we enrolled 15 105 civil servants from predefined universities or research institutes. Baseline assessment (2008–10) included detailed interviews and measurements to assess social and biological determinants of health, as well as various clinical and subclinical conditions related to diabetes, cardiovascular diseases and mental health. A second visit of interviews and examinations is under way (2012–14) to enrich the assessment of cohort exposures and to detect initial incident events. Annual surveillance has been conducted since 2009 for the ascertainment of incident events. Biological samples (sera, plasma, urine and DNA) obtained at both visits have been placed in long-term storage. Baseline data are available for analyses, and collaboration via specific research proposals directed to study investigators is welcome.

31 March 2012 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
EWEliana Wendland
Eliana Wendland
MTMaria Regina Torloni
Maria Regina Torloni
MFMaicon Falavigna
Maicon Falavigna
JTJanet Trujillo
Janet Trujillo
MDMaria Alice Dode
Maria Alice Dode
MSMaria Inês Schmidt
Maria Inês Schmidt
Two criteria based on a 2 h 75 g OGTT are being used for the diagnosis of gestational diabetes (GDM), those recommended over the years by the World Health Organization (WHO), and those recently recommended by the International Association for Diabetes in Pregnancy Study Group (IADPSG), the latter generated in the HAPO study and based on pregnancy outcomes. Our aim is to systematically review the evidence for the associations between GDM (according to these criteria) and adverse outcomes.

18 November 2014 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
MSMaria Inês Schmidt
Maria Inês Schmidt
JHJuliana F Hoffmann
Juliana F Hoffmann
MDMaria de Fátima Sander Diniz
Maria de Fátima Sander Diniz
PLPaulo A Lotufo
Paulo A Lotufo
RGRosane H. Griep
Rosane H. Griep
BDBruce Duncan
Bruce Duncan
The global burden of diabetes mellitus and other chronic diseases is high, and 80% of those with diabetes now live in low and middle income countries. Yet, little information is available regarding prevalence of diabetes and intermediate hyperglycemia in these countries, especially when a full range of diagnostic tests is employed. The purpose of this study is to provide a full accounting of these prevalences in a large, free-living Brazilian population. We report baseline data (2008-2010) from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil), a cohort study of 15,105 civil servants aged 35-74 years. Diabetes mellitus was ascertained by self-report of diagnosis, medication use, fasting glucose, an oral glucose tolerance test, and/or glycated hemoglobin. Cut-offs for diabetes and intermediate hyperglycemia followed the recommendations of the World Health Organization and the American Diabetes Association. Adjusted prevalences were estimated through logistic regression. With this full accounting, 19.7% (19.0%-20.3%) had diabetes mellitus, 50.4% being previously undiagnosed. Frequencies of intermediate hyperglycemia according to various criteria ranged from 16.1% to 52.6%. Diabetes or intermediate hyperglycemia was present in 79.1% of participants when using the most comprehensive definitions. The burden was greatest in the elderly, the obese, non-whites, and those with less formal education (p < 0.001). That four of every five free-living individuals aged 35-74 years working in selected public institutions in six Brazilian state capitals presented either diabetes or intermediate hyperglycemia highlights the advanced stage of the obesity – diabetes epidemic in urban Brazil and indicates the need for urgent action.

17 January 2022 in Nature Reviews Endocrinology
Verified
Journal Article
Closed access
PDF file
MFMichael Fralick
Michael Fralick
AJAlicia Jenkins
Alicia Jenkins
KKKamlesh Khunti
Kamlesh Khunti
JMJean Claude Mbanya
Jean Claude Mbanya
VMViswanathan Mohan
Viswanathan Mohan
MSMaria Inês Schmidt
Maria Inês Schmidt

22 November 2017 in Population Health Metrics
Verified
Journal Article
Open access
PDF file
EFElisabeth B. França
Elisabeth B. França
VPValéria Maria de Azeredo Passos
Valéria Maria de Azeredo Passos
DMDeborah Malta
Deborah Malta
BDBruce Duncan
Bruce Duncan
ARAntonio Luiz Ribeiro
Antonio Luiz Ribeiro
MNMohsen Naghavi
Mohsen Naghavi
Reliable data on cause of death (COD) are fundamental for planning and resource allocation priorities. We used GBD 2015 estimates to examine levels and trends for the leading causes of death in Brazil from 1990 to 2015. We describe the main analytical approaches focused on both overall and specific causes of death for Brazil and Brazilian states. There was an overall improvement in life expectancy at birth from 1990 to 2015, but with important heterogeneity among states. Reduced mortality due to diarrhea, lower respiratory infections, and other infectious diseases contributed the most for increasing life expectancy in most states from the North and Northeast regions. Reduced mortality due to cardiovascular diseases was the highest contributor in the South, Southeast, and Center West regions. However, among men, intentional injuries reduced life expectancy in 17 out of 27 states. Although age-standardized rates due to ischemic heart disease (IHD) and cerebrovascular disease declined over time, these remained the leading CODs in the country and states. In contrast, leading causes of premature mortality changed substantially - e.g., diarrheal diseases moved from 1st to 13th and then the 36th position in 1990, 2005, and 2015, respectively, while violence moved from 7th to 1st and to 2nd. Overall, the total age-standardized years of life lost (YLL) rate was reduced from 1990 to 2015, bringing the burden of premature deaths closer to expected rates given the country’s Socio-demographic Index (SDI). In 1990, IHD, stroke, diarrhea, neonatal preterm birth complications, road injury, and violence had ratios higher than the expected, while in 2015 only violence was higher, overall and in all states, according to the SDI. A widespread reduction of mortality levels occurred in Brazil from 1990 to 2015, particularly among children under 5 years old. Major shifts in mortality rates took place among communicable, maternal, neonatal, and nutritional disorders. The mortality profile has shifted to older ages with increases in non-communicable diseases as well as premature deaths due to violence. Policymakers should address health interventions accordingly.